Clinical Trial Update: Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigates repurposing the HIV drug Nelfinavir to improve iron delivery to the bone marrow in patients with myelofibrosis and anemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Myelofibrosis

Drugs mentioned

• Nelfinavir (nelfinavir)

Snippet

Sponsor: University of California, Irvine | Conditions: Myelofibrosis, Myelofibrosis; Anemia | Phase 1, Phase 2 | Status: RECRUITING